Marine has been a Clinical Supply Optimization Specialist (CSOS) at Sanofi since July 2022. In this position, she focuses on identifying optimization levers to be tested at the study level, challenging trial designs to improve efficiency. She defines Interactive Response Technology (IRT) strategies for individual studies and leads efforts to standardize new features that enhance IRT usage and strengthen process robustness.
Marine developed IRT expertise through her previous role as a Drug Manager, during which she implemented multiple IRT solutions across a wide range of clinical studies, including complex trial designs. This hands-on experience provided her with deep technical knowledge and practical insights, which she now leverages to optimize clinical supply operations at Sanofi.
Marion has served as IRT (Interactive Response Technology) Governance Leader at Sanofi since March 2023. In this strategic role, she oversees partnerships with multiple IRT vendors and ensures the optimal allocation of clinical studies based on key performance indicators (KPIs) that are monitored monthly.
Her IRT expertise is built on seven years of experience as a Drug Manager (2016–2023), during which she led the implementation of multiple IRT systems across a wide range of clinical studies.
Marion has extensive experience supporting post-acquisition trial continuity and has collaborated closely with IRT vendors to shape Sanofi’s technology partnership strategy. She has been instrumental in the expansion and transformation of the IRT vendor ecosystem.
Passionate and accomplished technical and commercial leader in the genomics space with a track record of success in rapidly increasing revenue, driving operational efficiency and delighting customers.
Dr. Janna Manjelievskaia is the Director of Health Economics and Outcomes Research (HEOR) at Veradigm, where she leads a senior research team in designing and implementing rigorous studies using real-world data, including EMR, claims, and registry sources. Janna brings nearly 15 years of experience across research, academic, and government settings, with expertise in study design and methodology, surveys, patient-reported outcomes, and health economics. Before Veradigm, she was a Research Leader at Merative (formerly IBM Watson Health/Truven Health Analytics), where she led real-world data research initiatives focused on disease burden, post-marketing safety, and healthcare utilization. She has also served as adjunct faculty in health policy and holds a PhD in Health Policy from the University of the Sciences in Philadelphia and an MPH in Epidemiology and Biostatistics from Temple University. Outside the office, Janna enjoys Pilates and staying current with health and longevity research.
Dr. Machaon Bonafede is Vice President of Real World Evidence at Veradigm, where he leads a multidisciplinary team of researchers, data scientists, statisticians, and epidemiologists focused on generating actionable insights from real-world data. With deep expertise in health economics and outcomes research, Mac’s team conducts studies across therapeutic areas using diverse real-world datasets to inform payer, provider, and life science decision-making. Prior to joining Veradigm, he held roles at IBM Watson Health (including Truven Health Analytics) and served on the faculty at Albany College of Pharmacy, teaching research and statistical methods. He also lectures in health management and policy at the University of New Hampshire. Mac holds a PhD in health services research and policy and an MPH from the University of Rochester. Outside of work, he enjoys homesteading and tending to his family’s historic farmhouse.
Seasoned Supply Chain Quality Assurance leader with extensive experience driving cold chain integrity and compliance across complex multi-country pharmaceutical distribution networks. In her current role as Director of Distribution and Country Quality for EMEA at Santen, Ilvie oversees the quality governance and risk management strategies that ensure temperature-sensitive medicines are delivered reliably and safely throughout Europe, the Middle East, and Africa.
Ilvie holds an academic degree in Veterinary Medicine, complemented by executive education from MIT Sloan School of Management, underscoring her commitment to operational excellence and strategic Quality leadership in the pharmaceutical industry.
Alexis Monier is Vice President of International Logistics at bioMérieux, where he shapes and leads the company’s global logistics strategy to strengthen customer satisfaction, resilience, efficiency, and long‑term sustainability.
As a pharmacist and engineer with 20 years of experience in the healthcare industry, he combines a pharmaceutical background with operational expertise to drive transformation across complex global supply chains. He has led major initiatives that redesigned bioMérieux’s cold chain management, international distribution network, and accelerated the shift toward lower‑carbon transportation modes—achieving significant reductions in environmental impact while enhancing operational efficiency.
Catarina Soares is a Regulatory Manager – Pharmaceuticals within the CTIMPs Team at the UCL/UCLH Joint Research Office. She provides specialist guidance on clinical trial regulation and ICH-GCP across UCL‑sponsored studies, including CR UK & UCL Cancer Trials Centre studies. Her role includes a strong focus on IMP vendor qualification—particularly for the manufacturing and distribution of Investigational Medicinal Products—as well as review of Clinical Trial Application (CTA) IMP documentation. Prior to joining the Joint Research Office, Catarina gained extensive experience in hospital pharmacy and led CTIMP pharmacy activities in different NHS England hospitals, where she was responsible for assessing local pharmacy feasibility and capacity, coordinating trial set‑up and overseeing IMP management. Catarina holds a degree in Pharmaceutical Sciences and a Master of Science in Applied Pharmacology.
